HemoShear (“HS”) develops and utilizes proprietary systems for replicating human micro-environments, (such as that of the liver for example), and data-driven human disease models to more accurately conduct drug testing, rare disease discovery initiatives, and drug development / joint development and licensing of new disease treatments.